Notice of Special Interest (NOSI): Advancing the Science of Geriatric Palliative Care Sponsor Name: National Institutes of Health/DHHS Funding Opportunity Number: NOT-AG-20-041 Deadline Dates: This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2023. Program Objectives This Notice of Special Interest (NOSI) encourages research grant applications focused on palliative care in geriatric populations. This NOSI covers studies in a variety of settings including hospitals (and specific sites within hospitals including specialty medical or
The AGING Initiative would like to share an upcoming funding opportunity on behalf of the U.S. Deprescribing Research Network (USDeN): USDeN seeks an investigator team to participate in a funded electronic data harmonization initiative related to deprescribing. Currently, 4 health systems will soon begin participation in a Data Harmonization workgroup to demonstrate approaches to using routinely available electronic health data in trials of deprescribing. We are seeking a 5th site to join this workgroup. The project will span 24 months, with $70,000 of funding available for the new site
The Evidence-based Practice Center (EPC) Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Integrating Palliative Care in Ambulatory Care of Non-Cancer Serious Chronic Illness. It is available for your review and feedback until September 18, 2020 at the Effective Healthcare Web site. The purpose of the review is to evaluate effectiveness and implementation of interventions for integrating palliative care into ambulatory care for patients with serious life-threatening chronic illness or conditions other than cancer and
About the Webinar: Tuesday, September 1, 2020, 12:30-2:00 p.m. ET. Register here: This pre-application technical assistance webinar will provide an overview of the two NIH multimorbidity funding opportunity announcements (FOAs) listed below. These FOAs are soliciting innovative research to better understand, measure, and intervene on multimorbidity, or multiple chronic conditions. · PAR-20-179: Advancing Research To Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) · PAR-20-180: Identifying Innovative Mechanisms or Interventions That Target
2021 Harvard Medical School Workshop on Research Methods in Supportive Oncology This NCI-funded intensive 6-day workshop will provide an overview of fundamental methods in supportive oncology research (psychosocial oncology, palliative care, symptom management, and survivorship). Over the course of the workshop, participants will write a complete study protocol under the direct mentorship of expert faculty in the field of supportive oncology. Essential workshop topics include: creation of conceptual models, supportive care clinical trials, development of psychosocial interventions, decision
Join us Virtually! You are invited to the first annual Colorado Pragmatic Research in Health (@COPRHCon) National Conference, being held virtually this August and focused on the methods, models, and measures for planning pragmatic research. Ideal for clinical and translational investigators, including statisticians, dissemination and implementation scientists, health services and public health researchers, and program evaluators. Poster abstract submission deadline: May 22, 2020: http://coprhcon.com/Posters/ Register here: http://coprhcon.com/Register/
NINR is participating in NOT-OD-20-097, a recently issued Notice of Special Interest (NOSI) that highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. The NOSI can be accessed here: https://grants.nih.gov/grants/guide/notice-files/not-od-20-097.html Please note that this NOSI is for supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic. The parent study may be observational or a clinical study with a
Please see new dates for the release of PCORI's Phased Large Awards for Comparative Effectiveness Research PFA on June 9, 2020. The new deadline for required Letters of Intent will be September 29, 2020. Those invited to submit a full application will have until January 12, 2021. These new dates correspond to PCORI’s Cycle 3 2020 timeline. Visit the pre-announcement page for more information: PCORI Funding Opportunity.